Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Mini Review
  • Published:

Mini-Review

Antibiotic prophylaxis in patients receiving hematopoietic stem cell transplant

Bone Marrow Transplantation volume 29, pages 367–371 (2002)Cite this article

Abstract

Effective prophylaxis against specific infections has allowed increasingly potent conditioning regimens to be given, thereby prolonging survival in HSCT recipients. The Centers for Disease Control and Prevention, in collaboration with numerous professional societies, has recently published guidelines to codify and advance this approach. Controversy remains in several areas but, curiously, the most intense debate concerns prevention of bacterial infections, the most extensively studied of all of the approaches. Central to this debate are the competing priorities of a potentially ill patient on the one hand vs the long-term consequences of unchecked antibiotic use. The emergence in the 1990s of vancomycin-resistant Enterococcus demonstrated all too vividly how devastating such an end result could be. This article will review the arguments for and against the routine use of antibacterial prophylaxis in HSCT recipients.

Bone Marrow Transplantation (2002) 29, 367–371. doi:10.1038/sj.bmt.1703366

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Centers for Disease Control and Surveillance. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of the CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow transplantation MMWR Morb Mortal Wkly Rev 2000 49: 1 125

  2. Cruciani M, Rampazzo R, Malena M et al. Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis Clin Infect Dis 1996 23: 795 805

    Article  CAS  Google Scholar 

  3. Engels EA, Lau J, Barza M . Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis J Clin Oncol 1998 16: 1179 1187

    Article  CAS  Google Scholar 

  4. Nagatomo A, Watanabe K, Kunikane H et al. A randomized controlled trial of sulfamethoxazole/trimethoprim plus norfloxacin versus sulfamethoxazole/trimethoprim alone for the prophylaxis of bacteria infection during chemotherapy for lung cancer Lung Cancer 1998 19: 121 125

    Article  CAS  Google Scholar 

  5. Murphy M, Brown AE, Sepkowitz KA et al. Fluoroquinolone prophylaxis for the prevention of bacterial infections in patients with cancer Clin Infect Dis 1997 25: 346 347

    Article  CAS  Google Scholar 

  6. De Pauw BE, Donnelly JP . Infections in the immunocompromised host: general principles. In: Mandell GL, Bennett JE, Dolin R (eds) Principles and Practice of Infectious Disease,5th edn Churchill-Livingstone: Philadelphia, PA 2000 3079 3090

    Google Scholar 

  7. Baum HV, Franz U, Geiss HK . Prevalence of ciprofloxacin-resistant Escherichia coli in hematologic–oncologic patients Infection 2000 28: 278 281

    Article  CAS  Google Scholar 

  8. Yeh SP, Hsueh EJ, Yu MS et al. Oral ciprofloxacin as antibacterial prophylaxis after allogeneic bone marrow transplantation: a reappraisal Bone Marrow Transplant 1999 24: 1207 1211

    Article  CAS  Google Scholar 

  9. Beelen DW, Elmaagacli A, Muller KD et al. Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and long-term follow-up of an open-label prospective randomized trial Blood 1999 93: 3267 3275

    CAS  Google Scholar 

  10. Carlens S, Ringden O, Aschan J et al. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination Clin Transplant 1998 12: 84 92

    CAS  PubMed  Google Scholar 

  11. Cometta A, Calandra T, Bille J, Glauser MP . Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia New Engl J Med 1994 330: 1240 1241

    Article  CAS  Google Scholar 

  12. Low DE, Keller N, Barth A, Jones RN . Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997–1999 Clin Infect Dis 2001 32: (Suppl. 2) S133 S145

    Article  CAS  Google Scholar 

  13. Tsiodras S, Gold HS, Sakoulas G et al. Linezolid resistance in a clinical isolate of Staphylococcus aureus Lancet 2001 358: 207 208

    Article  CAS  Google Scholar 

  14. Gonzales RD, Schreckenberger PC, Graham MB et al. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid Lancet 2001 357: 1179

    Article  CAS  Google Scholar 

  15. Attal M, Schlaifer D, Rubie H et al. Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial J Clin Oncol 1991 9: 865 870

    Article  CAS  Google Scholar 

  16. Elting LS, Bodey GP, Keefe BH . Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors Clin Infect Dis 1992 14: 1201 1207

    Article  CAS  Google Scholar 

  17. Bochud PY, Eggiman P, Calandra T et al. Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors Clin Infect Dis 1994 18: 25 31

    Article  CAS  Google Scholar 

  18. Marron A, Carratala J, Gonzalez-Barca E et al. Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer Clin Infect Dis 2000 31: 1126 1130

    Article  CAS  Google Scholar 

  19. Bochud PY, Calandra T, Francioli P . Bacteremia due to viridans streptococci in neutropenic patients: a review Am J Med 1994 97: 256 264

    Article  CAS  Google Scholar 

  20. Diekema DJ, Beach ML, Pfaller MA, Jones RN . Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America Clin Microbiol Infect 2001 7: 152 157

    Article  CAS  Google Scholar 

  21. Alfieri N, Ramotar K, Armstrong P et al. Two consecutive outbreaks of Stenotrophomonas maltophilia (Xanthomonas maltophilia) in an intensive-care unit defined by restriction fragment-length polymorphism typing Infect Control Hosp Epidemiol 1999 20: 553 556

    Article  CAS  Google Scholar 

  22. Bergogne-Berezin E . The increasing role of Acinetobacter species as nosocomial pathogens Curr Infect Dis Rep 2001 5: 440 444

    Article  Google Scholar 

  23. Donskey CJ, Chowdhry TK, Hecker MT et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients New Engl J Med 2000 343: 1925 1932

    Article  CAS  Google Scholar 

  24. Lee CE, Zembower TR, Fotis MA et al. The incidence of antimicrobial allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacterial resistance Arch Intern Med 2000 160: 2819 2822

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Infectious Diseases Section, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

    KA Sepkowitz

Authors
  1. KA Sepkowitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sepkowitz, K. Antibiotic prophylaxis in patients receiving hematopoietic stem cell transplant. Bone Marrow Transplant 29, 367–371 (2002). https://doi.org/10.1038/sj.bmt.1703366

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703366

Keywords

This article is cited by

Search

Advanced search

Quick links